{"id":"https://openalex.org/W2590841070","doi":"https://doi.org/10.1182/blood.v104.11.4737.4737","title":"Phase II Trial of Darbepoetin Alfa in Myelodysplastic Syndrome (MDS): Preliminary Efficacy, Safety, and In Vitro Results.","display_name":"Phase II Trial of Darbepoetin Alfa in Myelodysplastic Syndrome (MDS): Preliminary Efficacy, Safety, and In Vitro Results.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2590841070","doi":"https://doi.org/10.1182/blood.v104.11.4737.4737","mag":"2590841070"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.4737.4737","doi":"https://doi.org/10.1182/blood.v104.11.4737.4737","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4737.4737","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065621786","display_name":"Jason R. Gotlib","orcid":"https://orcid.org/0000-0001-8253-6156","observed_orcids":["https://orcid.org/0000-0001-8253-6156"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Gotlib","raw_affiliation_strings":["Hematology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082585348","display_name":"Sylvia Quesada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sylvia Quesada","raw_affiliation_strings":["Hematology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003007216","display_name":"Jyoti K. Bhamidipati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jyoti Bhamidipati","raw_affiliation_strings":["Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041097639","display_name":"Kamran Chaudry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamran Chaudry","raw_affiliation_strings":["Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055624947","display_name":"Kunju Joshi Sridhar","orcid":"https://orcid.org/0009-0006-5226-2960","observed_orcids":["https://orcid.org/0009-0006-5226-2960"]},"institutions":[{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]},{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kunju Sridhar","raw_affiliation_strings":["Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","Hematology, Stanford Cancer Center, Stanford, CA, USA","Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA; Hematology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]},{"raw_affiliation_string":"Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA; Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I204866599","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044947932","display_name":"Kathleen Dugan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Dugan","raw_affiliation_strings":["Hematology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Stein","raw_affiliation_strings":["Hematology/Stem Cell Transplant, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Stem Cell Transplant, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058390894","display_name":"Germaine Tupper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Germaine Tupper","raw_affiliation_strings":["Amgen, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041683169","display_name":"Peter L. Greenberg","orcid":"https://orcid.org/0000-0002-7615-9443","observed_orcids":["https://orcid.org/0000-0002-7615-9443"]},"institutions":[{"id":"https://openalex.org/I204866599","display_name":"VA Palo Alto Health Care System","ror":"https://ror.org/00nr17z89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I204866599","https://openalex.org/I2799886695","https://openalex.org/I4210125474"]},{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter L. Greenberg","raw_affiliation_strings":["Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","Hematology, Stanford Cancer Center, Stanford, CA, USA","Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA; Hematology, Stanford Cancer Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA","institution_ids":["https://openalex.org/I204866599"]},{"raw_affiliation_string":"Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Hematology, Palo Alto Veterans Health Care System, Palo Alto, CA, USA; Hematology, Stanford Cancer Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I204866599","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.28,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.81208276,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"4737","last_page":"4737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.05009999871253967,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darbepoetin-alfa","display_name":"darbepoetin alfa","score":0.9950000047683716},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/erythropoietin-analogs","display_name":"erythropoietin analogs","score":0.8149999976158142},{"id":"https://openalex.org/keywords/erythroid-response","display_name":"erythroid response","score":0.8569999933242798},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion-dependence","display_name":"red blood cell transfusion dependence","score":0.7440000176429749},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5630000233650208},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.6140000224113464},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.47600001096725464},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.335999995470047},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.42399999499320984},{"id":"https://openalex.org/keywords/refractory-anemia","display_name":"refractory anemia","score":0.4950000047683716},{"id":"https://openalex.org/keywords/refractory-anemia-with-ringed-sideroblasts","display_name":"refractory anemia with ringed sideroblasts","score":0.7929999828338623},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C2781404941","wikidata":"https://www.wikidata.org/wiki/Q2178381","display_name":"Darbepoetin alfa","level":3,"score":0.899276614189148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8346289396286011},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.6920856237411499},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5746281147003174},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5018424987792969},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.46514904499053955},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.45767778158187866},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44924068450927734},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4352295696735382},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4334478974342346},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42922961711883545},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3260551691055298}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.4737.4737","doi":"https://doi.org/10.1182/blood.v104.11.4737.4737","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4737.4737","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2067804675","https://openalex.org/W2550514007","https://openalex.org/W1986544757","https://openalex.org/W2551697620","https://openalex.org/W2966344671","https://openalex.org/W2576988132","https://openalex.org/W2094918417","https://openalex.org/W2093818690","https://openalex.org/W2253612270","https://openalex.org/W2538882843"],"abstract_inverted_index":{"Abstract":[0],"Recombinant":[1],"human":[2],"erythropoietin":[3],"(EPO)":[4],"has":[5],"been":[6,182],"evaluated":[7,53],"in":[8,30,49,64,273,330,347,390,400,452],"MDS":[9,65,357,453],"using":[10],"a":[11,37,43,76,103,129,155],"spectrum":[12],"of":[13,28,40,59,239,338,342,363,395,410,457],"doses":[14],"and":[15,47,56,202,263,302,306,344,399,439],"schedules,":[16],"usually":[17],"daily":[18],"or":[19,169,325,449],"thrice":[20],"weekly,":[21],"with":[22,42,75,229,285,292,359,371,375,386,413,443,448],"an":[23,145,151],"average":[24],"erythroid":[25,105,131,152,211,242,252,350,441],"response":[26,106,113,153,172],"rate":[27],"20%":[29],"published":[31],"trials.":[32],"Darbepoetin":[33],"alfa":[34],"(DA)":[35],"is":[36],"hyperglycosylated":[38],"analog":[39],"EPO":[41,73,345,423],"longer":[44],"serum":[45,407],"half-life":[46],"greater":[48],"vivo":[50,401],"potency.":[51],"We":[52],"the":[54,87,115,206,240,249,339,405],"efficacy":[55,368,402],"safety":[57],"profile":[58],"weekly":[60,137,445],"subcutaneous":[61],"DA":[62,90,116,141,255,259,264,270,280,343,376,411,420,446],"dosing":[63,447],"patients":[66,127,275,312],"(pts)":[67],"who":[68,99],"had":[69],"not":[70,101],"received":[71],"prior":[72],"treatment,":[74],"hemoglobin":[77],"(Hb)":[78],"\u2264":[79],"10g/dL":[80],"and/or":[81],"red":[82],"blood":[83],"cell":[84],"transfusion-dependence.":[85],"During":[86],"induction":[88],"phase,":[89],"was":[91,118,138,244,271,281],"begun":[92],"at":[93],"4.5":[94,256],"mcg/kg/week":[95],"(wk).":[96],"For":[97],"pts":[98,180,208,332,358],"did":[100],"achieve":[102],"major":[104,130,220,241,251],"by":[107],"6":[108,124,147],"wks":[109],"(International":[110],"Working":[111],"Group":[112],"criteria),":[114],"dose":[117],"doubled":[119],"to":[120,140,323,404],"9":[121,142,260,265],"mcg/kg/wk":[122,143,257,261,266],"for":[123,144,163,210,248,276,314,355],"wks.":[125,148],"In":[126,426],"without":[128,450],"response,":[132],"G-CSF":[133,268,451],"2.5":[134],"mcg/kg":[135],"twice":[136],"added":[139],"additional":[146],"Patients":[149],"achieving":[150],"underwent":[154],"\u2265":[156,164,174],"3-month":[157],"maintenance":[158],"phase.":[159],"Dose":[160],"reduction":[161],"occurred":[162,329,369],"grade":[165,299,307,327],"3":[166,230,308,311,324,331],"non-hematologic":[167,288],"toxicity":[168],"excess":[170,277],"Hb":[171,278],"(Hb":[173],"13":[175],"g/dL).":[176],"To":[177],"date,":[178],"12":[179],"have":[181],"enrolled.":[183],"FAB":[184],"diagnoses":[185],"were:":[186,254,419],"RA":[187],"(n=3),":[188],"RARS":[189],"(n=5),":[190],"CMML":[191],"(n=1),":[192],"RAEB":[193],"(n=3);":[194],"divided":[195],"into":[196],"IPSS":[197],"Low":[198],"(n=6),":[199],"Intermediate-1":[200],"(n=4)":[201],"Intermediate-2":[203],"(n=2).":[204],"Of":[205,310],"10":[207],"evaluable":[209],"responses":[212,243,392,442],"(2":[213,232,333],"were":[214],"too":[215],"early),":[216],"7":[217,364],"responded:":[218],"5":[219,250],"(3":[221],"RA,":[222],"2":[223,225,274,300,322],"RARS),":[224],"minor":[226],"(RARS,":[227],"RAEB),":[228],"non-responders":[231],"RAEB,":[233,334],"1":[234,316,335],"RARS).":[235,336],"The":[236],"median":[237],"durability":[238],"12.5":[245],"months.":[246],"Doses":[247],"responders":[253],"(1),":[258,262],"+":[267],"(3).":[269],"dose-reduced":[272],"response.":[279],"generally":[282],"well":[283],"tolerated":[284],"no":[286],"unexpected":[287],"toxicity.":[289],"One":[290],"pt":[291],"baseline":[293],"diabetic":[294],"chronic":[295],"renal":[296],"insufficiency":[297],"developed":[298],"proteinuria":[301],"increased":[303],"creatinine":[304],"levels,":[305],"hypertension.":[309],"hospitalized":[313],"pneumonia,":[315],"(RAEB)":[317],"expired.":[318],"Progressive":[319],"thrombocytopenia":[320],"(grade":[321],"worsening":[326],"3)":[328],"Evaluation":[337],"stimulatory":[340,379,417],"effects":[341],"on":[346],"vitro":[348,391,428],"marrow":[349,373],"colony":[351],"formation":[352],"indicated":[353],"that":[354],"those":[356],"BFU-E":[360,367],"growth":[361],"(4":[362],"pts),":[365],"similar":[366],"compared":[370,412],"normal":[372],"(n=7),":[374],"being":[377,431],"less":[378],"than":[380],"EPO.":[381],"These":[382,433],"findings":[383],"are":[384,430],"consistent":[385],"known":[387],"differences":[388],"between":[389],"(a":[393],"function":[394],"receptor":[396],"binding":[397],"affinities)":[398],"(related":[403],"extended":[406],"half":[408],"life":[409],"EPO).":[414],"Plateau":[415],"(peak)/2":[416],"concentrations":[418],"1nM":[421],"(37ng/ml),":[422],"0.2nM":[424],"(0.78U/ml).":[425],"vivo/in":[427],"correlations":[429],"assessed.":[432],"initial":[434],"data":[435],"indicate":[436],"good":[437],"tolerability":[438],"encouraging":[440],"once":[444],"pts.":[454],"Updated":[455],"results":[456],"ongoing":[458],"accrual":[459],"will":[460],"be":[461],"presented.":[462]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2017-03-03T00:00:00"}